Your Results

For our final podcast of 2024 we present the perfect opportunity for you to reflect and consider what behaviour change means to you and your practice.

It is time for our final PCRS in Conversation webinar of 2024. To mark the occasion we have special guest Katya Miles, aka The Working Well Doctor, to chat to Katherine and share with you all how to work well, and support your wellbeing.Katya is a former GP and Occupational Health Doctor whose full focus is now Leadership & Resilience Training, Career Coaching and Retreats - and together with Katherine they will share their experiences and their guidance as to how you can thrive.

This year’s conference was a resounding success, cementing its place as a highlight in the PCRS calendar.With five parallel streams dedicated to clinical practice, service development, professional growth, hands-on workshops, and the latest research, the conference offered something for everyone.

The Primary Care Respiratory Society (PCRS) advocates that:vaping should be discouraged among children and young people;accurate information should be available for them, their families, schools and health professionals around the potential risks of vaping, in terms of a gateway product for other addictive behaviours; andthat long-term safety data should be available for this age group in regulated products.

A study published in The Lancet shows that, in 2022, more than 1 billion people in the world are living with obesity. The relationship between obesity and respiratory health is complex, involving mechanical, inflammatory, and metabolic factors. New research continues to grow a body of evidence on the impact of obesity on lung function and respiratory conditions such as asthma.

Breathlessness is a common presenting symptom in primary care, and there are many causes.Early and accurate diagnosis is critical to ensuring patients receive the right treatment at the earliest opportunity.

The National Review of Asthma Deaths (NRAD) came out a decade ago, yet as a nation, we still have the highest asthma death rate in Europe - four times that of Italy or the Netherlands. This is unsurprising, considering many patients still rely on their blue inhalers alone.However:• Blue inhalers don’t treat inflammation• Brown inhalers don’t relieve symptoms quicklyFirst and foremost, the best inhaler is the inhaler the patient will use and identifying what this is should actively involve the patient.

On the 28th November the joint National Institute for Health and Care Excellence (NICE), British Thoracic Society (BTS) and Scottish Intercollegiate Guidelines Network (SIGN) will publish their long-awaited single guideline on asthma diagnosis, monitoring and management.